rs144605615
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001278116.2(L1CAM):c.28C>T(p.Pro10Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00163 in 1,208,295 control chromosomes in the GnomAD database, including 18 homozygotes. There are 492 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001278116.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
L1CAM | NM_001278116.2 | c.28C>T | p.Pro10Ser | missense_variant | 2/29 | ENST00000370060.7 | |
L1CAM | NM_000425.5 | c.28C>T | p.Pro10Ser | missense_variant | 1/28 | ||
L1CAM | NM_024003.3 | c.28C>T | p.Pro10Ser | missense_variant | 1/27 | ||
L1CAM | NM_001143963.2 | c.28C>T | p.Pro10Ser | missense_variant | 1/26 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
L1CAM | ENST00000370060.7 | c.28C>T | p.Pro10Ser | missense_variant | 2/29 | 5 | NM_001278116.2 | A1 |
Frequencies
GnomAD3 genomes ? AF: 0.00891 AC: 993AN: 111504Hom.: 10 Cov.: 23 AF XY: 0.00703 AC XY: 237AN XY: 33716
GnomAD3 exomes AF: 0.00261 AC: 473AN: 180985Hom.: 5 AF XY: 0.00151 AC XY: 100AN XY: 66223
GnomAD4 exome AF: 0.000894 AC: 980AN: 1096740Hom.: 8 Cov.: 31 AF XY: 0.000701 AC XY: 254AN XY: 362462
GnomAD4 genome ? AF: 0.00892 AC: 995AN: 111555Hom.: 10 Cov.: 23 AF XY: 0.00705 AC XY: 238AN XY: 33777
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Nov 23, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 30, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 14, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 01, 2013 | - - |
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 24, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at